Evidence mapPaperPMID 41987078Full record

ArticleBMC infectious diseases2026

Prevalence and molecular characterization of ESBL-producing Enterobacterales in clinical samples from the Boucle du Mouhoun region in Burkina Faso.

Hiliassa Coulibaly, Dissinviel Stéphane Kpoda, Hervé Kafando, Oumar Traoré, Alix Bénédicte Kagambega, Alassane Halawen Mohamed, Robin Fréderic, Racha Beyrouthy, Dramane Ouédraogo, Oumarou Soro and 4 more

Abstract read
In one paragraph

Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Hiliassa CoulibalyLaboratory of Molecular Biology, Epidemiology and Surveillance of Bacteria and Viruses Transmitted by Food, University Joseph KI-ZERBO, Ouagadougou, BP 7021, Burkina Faso. coulhiliassa@gmail.com.ORCID http://orcid.org/0009-0003-1837-8036
Dissinviel Stéphane KpodaMicrobiology and Microbial Biotechnology Laboratory, BP 7021, Ouagadougou , Burkina Faso.
Hervé KafandoBiomedical Laboratory of the Regional Hospital Centre of Dédougou, Dédougou, BP 176, Burkina Faso.
Oumar TraoréLaboratory of Molecular Biology, Epidemiology and Surveillance of Bacteria and Viruses Transmitted by Food, University Joseph KI-ZERBO, Ouagadougou, BP 7021, Burkina Faso.
Alix Bénédicte KagambegaLaboratory of Molecular Biology, Epidemiology and Surveillance of Bacteria and Viruses Transmitted by Food, University Joseph KI-ZERBO, Ouagadougou, BP 7021, Burkina Faso.
Alassane Halawen MohamedMicrobiology Laboratory of the General Reference Hospital, Niamey, BP 12674, Niger.
Robin FrédericUniversity Hospital Centre of Clermont-Ferrand, National Reference Centre (CNR) for Antibiotic Resistance, Clermont-Ferrand, BP 63 000, France.
Racha BeyrouthyUniversity Hospital Centre of Clermont-Ferrand, National Reference Centre (CNR) for Antibiotic Resistance, Clermont-Ferrand, BP 63 000, France.
Dramane OuédraogoBiomedical Laboratory of the Regional Hospital Centre of Dédougou, Dédougou, BP 176, Burkina Faso.
Oumarou SoroDepartment of Molecular Biology and Biotechnology, Pan African University Institute for Basic Sciences, Technology, and Innovation, P.O. Box 62000-00200, Nairobi, Kenya.
Dominique BayalaBiomedical Laboratory of the Regional Hospital Centre of Dédougou, Dédougou, BP 176, Burkina Faso.
Nicolas BarroLaboratory of Molecular Biology, Epidemiology and Surveillance of Bacteria and Viruses Transmitted by Food, University Joseph KI-ZERBO, Ouagadougou, BP 7021, Burkina Faso.
Richard BonnetUniversity Hospital Centre of Clermont-Ferrand, National Reference Centre (CNR) for Antibiotic Resistance, Clermont-Ferrand, BP 63 000, France.
René DembéléLaboratory of Molecular Biology, Epidemiology and Surveillance of Bacteria and Viruses Transmitted by Food, University Joseph KI-ZERBO, Ouagadougou, BP 7021, Burkina Faso.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExtended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae represent a major clinical and public health concern due to their ability to confer resistance to multiple classes of antibiotics. Data on the molecular epidemiology of ESBL-producing Escherichia coli and Klebsiella pneumoniae remain limited in many regions of Burkina Faso, particularly outside the Ouagadougou and Bobo Dioulasso. This study aimed to determine the frequency of ESBL-producing Escherichia coli and Klebsiella pneumoniae and to characterize the ESBL resistance genes circulating in the Boucle du Mouhoun region.

methodsA total of 1,845 clinical samples (urine, pus, blood, and semen) collected from patients attending two major healthcare facilities in Dédougou were processed during the study period. From these samples, 247 non-duplicate Escherichia coli and Klebsiella pneumoniae isolates were recovered and identified using API 20E and confirmed by MALDI-TOF mass spectrometry. Other Enterobacterales species identified during routine culture were excluded from subsequent analyses. Antimicrobial susceptibility testing was performed using the disk diffusion method. ESBL-encoding genes and Escherichia coli phylogenetic groups were characterized by polymerase chain reaction.

resultsAmong the 247 Enterobacterales isolates, Escherichia coli accounted for 78.1% (193/247) and Klebsiella pneumoniae for 21.86% (54/247). Overall, 55.0% (136/247) of the isolates were ESBL-producing, including 58.03% (112/193) of Escherichia coli and 44.44% (24/54) of Klebsiella pneumoniae. High levels of co-resistance were observed with fluoroquinolones (90.4%), trimethoprim-sulfamethoxazole (91.9%), and aminoglycosides (55.9%). Molecular analysis revealed a predominance of CTX-M-1-group genes (88.7%), followed by CTX-M-9-group genes (10.3%). Of the 112 ESBL-producing Escherichia coli isolates, 47.3% (53/112) belonged to phylogroup B2 and 42.9% (48/112) to phylogroup A.

conclusionsThis study provides the first molecular evidence of ESBL-producing Escherichia coli and Klebsiella pneumoniae in the Boucle du Mouhoun region of Burkina Faso. The high prevalence of blaCTX-M genes underscores the urgent need to strengthen antimicrobial stewardship programs, enhance infection prevention and control measures, and implement regular regional surveillance to curb the spread of multidrug-resistant Enterobacterales.

Indexed as

beta-LactamasesEscherichia coliEscherichia coli InfectionsKlebsiella InfectionsKlebsiella pneumoniaeAnti-Bacterial AgentsBurkina FasoHumansMicrobial Sensitivity TestsMolecular EpidemiologyPhylogenyPrevalenceAnti-Bacterial Agentsbeta-LactamasesAntimicrobial resistanceBurkina FasoESBL-producingEscherichia coliKlebsiella pneumoniae

Identifiers

PMID41987078
PMCPMC13202859

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.